HealthQuill Pharma
The US Food and Drug Administration has approved Britain’s GSK Plc’s drug to treat urinary tract infections in adult women and girls above 12 years, according to the company.
Drugs Medical Pharma

GSK’s drug to fight urinary tract infections gets USFDA approval

HQ Team March 26, 2025: The US Food and Drug Administration has approved Britain’s GSK Plc’s drug to treat urinary tract infections in.

Read More
The World Health Organization has issued new guidelines to help reform and strengthen mental health policies and systems at a time when up to 90% of the people in some nations with severe mental health conditions receive no care at all.
Health Medical Pharma

WHO unveils new guidelines to tackle mental health systems, policies

HQ Team March 26, 2025: The World Health Organization has issued new guidelines to help reform and strengthen mental health policies and systems.

Read More
Merck & Co., Inc. has bought global rights for an experimental oral drug to treat heart diseases from China’s Jiangsu Hengrui Pharmaceuticals Co., Ltd. in a $2 billion deal.
Drugs Health Pharma

Merck signs $2b licensing deal with Jiangsu Hengrui for heart disease drug

HQ Team March 25, 2025: Merck & Co., Inc. has bought global rights for an experimental oral drug to treat heart diseases from.

Read More
Novo Nordisk has inked a $2 billion licensing pact with United Laboratories International for the development, manufacturing and commercialising of the Chinese company’s “triple G” weight-loss candidate.
Drugs Medical Pharma

Novo Nordisk in $2b deal with Chinese firm for ‘triple-G’ obesity drug

HQ Team February 25, 2025: Novo Nordisk has inked a $2 billion licensing pact with United Laboratories International for the development, manufacturing and.

Read More
Progress in slowing child mortality and stillbirth deaths has received a severe blow due to funding cuts and shortages, with 1.9 million children dying in 2023 on account of stillbirths.
Drugs Health Pharma

Funding cuts ‘severely’ bleeding UN’s child survival, stillbirth programs

HQ Team March 25, 2025: Progress in slowing child mortality and stillbirth deaths has received a severe blow due to global funding cuts.

Read More
Nova Nordisk's Ozempic has changed he weight loss landscape
Drugs Pharma

Brazil’s pharma giant Hypera to launch generic Ozempic in 2026

Bharti Jayshankar March 24, 2025: Brazilian pharmaceutical giant Hypera announced plans to introduce a generic version of semaglutide—the active ingredient in Novo Nordisk’s.

Read More
AstraZeneca’s drug for treating limited-stage small cell lung cancer got a recommendation for approval from an EU regulator panel, according to the British-Swedish drugmaker.
Pharma

AstraZeneca to invest $2.5 Billion in Beijing R&D hub, expands China presence

HQ Team March 21, 2025: AstraZeneca has announced a $2.5 billion investment in a new Beijing R&D center, partnerships with Harbour BioMed and.

Read More
British-Swedish AstraZeneca and Japan's Daiichi Sankyo’s investigational drug for breast cancer failed to significantly improve the overall survival of the patients during an end-stage trial, according to a joint statement.
Pharma

AstraZeneca acquires EsoBiotec for $1billion in a bid to push its cell therapy agenda

HQ Team March 17, 2025: AstraZeneca has announced plans to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies, for up to.

Read More
China’s WuXi Biologics, a clinical research organization, has granted global rights to US-based Candid Therapeutics to use the company’s synthetic antibody to fight cancer for an upfront payment of $925 million.
Pharma

Gilead’s once-yearly lenacapavir shot for HIV prevention shows strong promise

HQ Team March 12, 2025: In a significant development for HIV prevention, Gilead Sciences has unveiled promising data from its Phase 1 study.

Read More
Roche and Zealnd pharma go in for a $5.3billion deal for obesity candidate
Pharma

Roche secures Zealand pharma’s obesity drug in $5.3 billion deal

HQ Team March 12, 2025: Swiss pharmaceutical giant Roche has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma to.

Read More